Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DGX compared with CSTL: revenue, margins and what each company keeps, and the suppliers and customers both name
DGX
Quest Diagnostics Inc
Change
Mkt cap
Revenue
Revenue
CSTL
Castle Biosciences Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
DGX
Quest Diagnostics Inc
vs
CSTL
Castle Biosciences Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
DGX
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±6.7%
▲
+1.82%
×0.27
Q2 FY26
±7.6%
▲
+8.61%
×1.13
Q1 FY26
±5.8%
▲
+4.45%
×0.78
Feb 10 '26
±4.2%
▲
+7.37%
×1.76
CSTL
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±15.4%
▲
+4.52%
×0.29
May 7 '26
±19.4%
▼
−22.26%
×1.15
= implied
DGX realized, solid
CSTL realized, hatched
One scale, both sides: full bar = 23%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±15.2%
▼
−7.25%
×0.48
Jan 13 '26
±7.7%
▼
−0.05%
×0.01
DGX
Quest Diagnostics Inc
Change
251.71
· pre 252.26
· delayed
Mkt cap
$27.7B
Revenue
$3.1B
Q3 FY26
Revenue
$11.0B
FY25
CSTL
Castle Biosciences Inc
Change
38.47
· pre 37.19
Pre-market
Sep 2 '83
Mkt cap
$1.1B
Revenue
$104M
Q2 FY26
Revenue
$344M
FY25
vs
Compare
Pre-market
Sep 2 '83
DGX
Quest Diagnostics Inc
vs
CSTL
Castle Biosciences Inc
251.71
pre 252.26
delayed
Price
38.47
pre 37.19
$27.7B
Mkt cap
$1.1B
Q3 FY26
$3.1B
Revenue
$104M
Q2 FY26
FY25
$11.0B
Revenue
$344M
FY25
Change
Change
DGX
251.71
vs
CSTL
38.47
Pre-market
Sep 2 '83